A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-
Clinical trial NCT00189748 · COMPLETED
Trial details
- NCT number
- NCT00189748
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.